360 related articles for article (PubMed ID: 31684070)
1. Problems Associated with Deprescribing of Proton Pump Inhibitors.
Helgadottir H; Bjornsson ES
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070
[TBL] [Abstract][Full Text] [Related]
2. Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
Boghossian TA; Rashid FJ; Thompson W; Welch V; Moayyedi P; Rojas-Fernandez C; Pottie K; Farrell B
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011969. PubMed ID: 28301676
[TBL] [Abstract][Full Text] [Related]
3. Deprescribing proton pump inhibitors.
Turner JP; Thompson W; Reeve E; Bell JS
Aust J Gen Pract; 2022 Nov; 51(11):845-848. PubMed ID: 36310001
[TBL] [Abstract][Full Text] [Related]
4. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
Dharmarajan TS
J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
[TBL] [Abstract][Full Text] [Related]
5. Successful deprescribing of unnecessary proton pump inhibitors in a primary care clinic.
Odenthal DR; Philbrick AM; Harris IM
J Am Pharm Assoc (2003); 2020; 60(1):100-104. PubMed ID: 31601478
[TBL] [Abstract][Full Text] [Related]
6. Deprescribing in a family health team: a study of chronic proton pump inhibitor use.
Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK
J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559
[TBL] [Abstract][Full Text] [Related]
7. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
9. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?
Namikawa K; Björnsson ES
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791497
[TBL] [Abstract][Full Text] [Related]
10. Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project.
Calvo LLJ; García Cámara P; Llorente Barrio M; Sierra Gabarda O; Monzón Baez R; Arbonés Mainar JM; Alcedo González J; Bernal Monterde V
Eur J Clin Pharmacol; 2021 Dec; 77(12):1927-1933. PubMed ID: 34269841
[TBL] [Abstract][Full Text] [Related]
11. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
Lee L; Ramos-Alvarez I; Ito T; Jensen RT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
14. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
Rababa M; Rababa'h A
BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
[TBL] [Abstract][Full Text] [Related]
15. Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey.
Kurlander JE; Kennedy JK; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Saini SD
Am J Gastroenterol; 2019 Feb; 114(2):244-249. PubMed ID: 30694867
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop.
Kahrilas P; Anastasiou F; Bredenoord AJ; El Serag HB; Labenz J; Mendive J; Savarino EV; Sifrim D; Udrescu M; Yadlapati R; Hungin AP
Dig Dis; 2024; 42(3):211-220. PubMed ID: 38513623
[TBL] [Abstract][Full Text] [Related]
17. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Targownik LE; Fisher DA; Saini SD
Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
[TBL] [Abstract][Full Text] [Related]
18. We have had a gutful: The need for deprescribing proton pump inhibitors.
Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
[TBL] [Abstract][Full Text] [Related]
19. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.
Jianu CS; Lange OJ; Viset T; Qvigstad G; Martinsen TC; Fougner R; Kleveland PM; Fossmark R; Hauso Ø; Waldum HL
Scand J Gastroenterol; 2012 Jan; 47(1):64-7. PubMed ID: 22087794
[TBL] [Abstract][Full Text] [Related]
20. Strategies for discontinuation of proton pump inhibitors: a systematic review.
Haastrup P; Paulsen MS; Begtrup LM; Hansen JM; Jarbøl DE
Fam Pract; 2014 Dec; 31(6):625-30. PubMed ID: 25192903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
